In a groundbreaking move, the City of Geneva revealed its venture into the green bonds arena, successfully raising an impressive CHF 140 million in aggregate principal amount. This marks the City’s inaugural foray into green
The Swiss Financial Market Supervisory Authority FINMA has given the green light to Alpadis Trust for its trustee application under the Financial Institutions Act (FINIA). Alpadis Group, a global fiduciary group based in Switzerland, specializes
In a strategic move to advance innovation in the Infection Control and Life Science domain, Metall Zug and Miele have inked a transformative agreement. The deal outlines the creation of a new joint venture, where
Baker McKenzie advised Commerzbank Aktiengesellschaft and Credit Suisse (Switzerland) Ltd. in their capacities as joint mandated lead arrangers, coordinators and bookrunners in connection with a CHF 500-million senior multicurrency revolving credit facility agreement for Geberit,
In a strategic move, Ringier has successfully acquired all shares in the former Swiss joint venture, Ringier Axel Springer Schweiz (RASCH), from Axel Springer. The joint venture, established in 2016, has been a collaborative effort until
In its ruling of 20 November 2023, the Federal Administrative Court fully upheld an appeal by Holzkraftwerk Aarberg and decided that the electricity generated with so-called problematic wood waste (A IV wood) must also be remunerated at
Kohlberg Kravis Roberts (KKR) makes a significant investment into the Precipart Group, a renowned contract manufacturer of high-precision components to the medical, aerospace and industrial markets. KKR plans to support the company in its continued
The Danish company Kimbrer Computer, a supplier of used IT equipment and a Trill Impact portfolio company, has acquired Renewtech, a provider of circular IT services and networking solutions. The acquisition of Renewtech also marks
In a resounding success, Lonza has secured its financial future by placing two tranches totaling CHF 400 million. The first tranche of CHF 185 million, featuring a 2.25% interest rate and maturing in 2028, was complemented by a second
In a groundbreaking move, Boehringer Ingelheim has sealed the deal to acquire T3 Pharmaceuticals, a dynamic Swiss biotech company, for a staggering amount of up to 450 million CHF. This strategic move signals a major leap
